CLDN18 Protein: Target Overview, Research Applications, and Selection Guide

15 products

Claudin 18 (CLDN18) is a member of the claudin family of tight junction proteins, which are essential components of epithelial barrier structures. CLDN18 exists in two main isoforms, CLDN18.1 and CLDN18.2, generated through alternative splicing. Among these, CLDN18.2 has emerged as a clinically relevant tumor-associated antigen, particularly in gastric and pancreatic cancers. Under normal physiological conditions, CLDN18.2 is largely confined to gastric mucosa and is buried within tight junctions, limiting antibody accessibility. However, in malignant transformation, tight junction disruption exposes CLDN18.2 on the cell surface, making it an attractive and highly specific therapeutic target.

CLDN18 Target Overview

CLDN18 is a four-pass transmembrane protein localized at tight junctions, functioning primarily in epithelial barrier maintenance. It plays roles in:

  • Regulation of paracellular permeability 
  • Maintenance of epithelial polarity 
  • Cell–cell adhesion 
  • Tumor-specific antigen exposure (CLDN18.2) 

A key feature of CLDN18.2 is its tumor-restricted accessibility, which distinguishes it from many broadly expressed membrane targets. While not a signaling receptor or enzyme, CLDN18.2 serves as a structural and targeting antigen, enabling selective antibody-based therapies.

Key Research Applications of CLDN18 Protein

CLDN18 is primarily used in oncology and antibody development workflows, especially for CLDN18.2-targeted therapies.

1. Tumor Target Validation

  • Expression profiling in gastric and pancreatic cancers 
  • Surface exposure analysis in tumor vs normal tissue 
  • Biomarker validation for patient stratification 

2. Antibody Discovery and Engineering

  • Screening of anti-CLDN18.2 antibodies 
  • Epitope mapping and affinity optimization 
  • Fc engineering for enhanced effector function 

3. Immunotherapy Studies

  • ADCC and CDC functional assays 
  • Effector cell recruitment and activation studies 
  • Combination therapy evaluation 

4. Cell-Based Functional Assays

  • Membrane localization validation 
  • Internalization and antibody binding assays 
  • Flow cytometry and imaging-based assays

Browse Our CLDN18 Products

Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.

Fast turnaround production is available at a affordable price point if none of our catalog products fits your desire specifications.

Filters

    15 products